Androgen-independent prostate cancer progression in the TRAMP model

Cancer Research

Volumn 57, Issue 21, 1997, Pages 4687-4691

  Gingrich, Jeffrey R ^a,c   Barrios, Roberto J ^a   Kattan, Michael W ^a   Nahm, Hyun S ^b   Finegold, Milton J ^a   Greenberg, Norman M ^a,b  

^a TEXAS CHILDREN S HOSPITAL   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; ONCOPROTEIN;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER GROWTH; CANCER HORMONE THERAPY; CASTRATION; CONTROLLED STUDY; HORMONE SENSITIVITY; LYMPH NODE METASTASIS; MALE; NONHUMAN; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; PROSTATE CANCER; PROTEIN EXPRESSION; RAT; TRANSGENIC MOUSE;

ADENOCARCINOMA; ANIMALS; CARCINOMA IN SITU; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; LYMPHATIC METASTASIS; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; NEOPLASM INVASIVENESS; NEOPLASM PROTEINS; ONCOGENE PROTEINS; ORCHIECTOMY; ORGAN SIZE; PROSTATE; PROSTATIC NEOPLASMS; SEMINAL VESICLES; URINARY BLADDER;

EID: 0030727885     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Huggins, C., and Hodges, C. V. Studies on prostatic cancer: effect of castration, of estrogen, and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate. Cancer Res., 1: 293-297, 1941.
2. Lepor, H., Ross, A., and Walsh, P. C. The influence of hormonal therapy on survival of men with advanced prostatic cancer. J. Urol., 128: 335-340, 1982.
3. Kramolowsky, E. V. The value of testosterone deprivation in stage D1 carcinoma of the prostate. J. Urol., 139: 1242-1244, 1988.
4. Schmidt, J. D. The case for early endocrine treatment of advanced or metastatic prostate cancer. Prostate, 28: 201-204, 1996.
5. Smith, P. H. Carcinoma of prostate: case against immediate hormonal therapy. Prostate, 28: 205-208, 1996.
6. Greenberg, N. M., DeMayo, F. J., Sheppard, P. C., Barrios, R., Lebovitz, R., Finegold, M., Angelopoulou, R., Dodd, J. G., Duckworth, M. L., Rosen, J. M., and Matusik, R. J. The rat probasin gene promoter directs hormonally-and developmentally-regulated expression of a heterologous gene specifically to the prostate in transgenic mice. Mol. Endocrinol., 8: 230-239, 1994.
7. Greenberg, N. M., DeMayo, F., Finegold, M. J., Medina, D., Tilley, W. D., Aspinall, J. O., Cunha, G. R., Donjacour, A. A., Matusik, R. J., and Rosen, J. M. Prostate cancer in a transgenic mouse. Proc. Natl. Acad. Sci. USA, 92: 3439-3443, 1995.
8. Gingrich, J. R., Barrios, R. J., Morton, R. A., Boyce, B. F., DeMayo, F. J., Finegold, M. J., Angelopoulou, R., Rosen, J. M., and Greenberg, N. M. Metastatic prostate cancer in a transgenic mouse. Cancer Res., 56: 4096-4102, 1996.
9. Sepulveda, A. H., Finegold, M. J., Smith, B., Slagle, B. L., DeMayo, J. L., Shen, R. F., Woo, S. L., and Butel, J. S. Development of a transgenic mouse system for the analysis of stages in liver carcinogenesis using tissue-specific expression of SV40 large T-antigen controlled by regulatory elements of the human α-1-antitrypsin gene. Cancer Res., 49: 6108-6117, 1989.
10. Itman, R. I. Some aspects of the rank transform in analysis of variance problems. Proceedings of the 7th Annual SUGI Conference, San Francisco, CA, February 14-17, 1982, pp. 676-80.
11. Isaacs, J. T., and Coffey, D. S. Adaptation versus selection as the mechanism responsible for the relapse of prostatic cancer to androgen ablation therapy as studied in the Dunning R-3327-H adenocarcinoma. Cancer Res., 41: 5070-5075, 1981.
12. Murphy, W., Soloway, M., and Barrows, G. Pathologic changes associated with androgen deprivation therapy for prostate cancer. Cancer (Phila.), 68: 821-828, 1991.
13. Foster, B., Gingrich, J., Kwon, E., Madias, C., and Greenberg, N. Characterization of prostatic epithelial cell lines derived from transgenic adenocarcinoma of the mouse (TRAMP) model. Cancer Res., 57: 3325-3330, 1997.
14. Bentel, J. M., and Tilley, W. D. Androgen receptors in prostate cancer. J. Endocrinol., 151: 1-11, 1996.
15. Tilley, W. D., Buchanan, G., Hickey, T. E., and Bentel, J. M. Mutations in the androgen receptor gene are associated with progression of human prostate cancer to androgen independence. Clin. Cancer Res., 2: 277-285, 1996.